Latest Articles

Publication Date
Computational image and molecular analysis reveal unique prognostic features of immune architecture in African Versus European American women with endometrial cancer - Nature

Computational image and molecular analysis reveal unique prognostic features of immune architecture in African Versus European American women with endometrial cancer Nature

Published: June 23, 2025, 7:30 a.m.
Integrating Deep Learning and Clinical Characteristics for Early Prediction of Endometrial Cancer Using Multimodal Ultrasound Imaging: A Multicenter Study - Frontiers

Integrating Deep Learning and Clinical Characteristics for Early Prediction of Endometrial Cancer Using Multimodal Ultrasound Imaging: A Multicenter Study Frontiers

Published: June 19, 2025, 2:09 p.m.
1st patient dosed in trial of Enhertu for HER2 endometrial cancer - Rare Cancer News

1st patient dosed in trial of Enhertu for HER2 endometrial cancer Rare Cancer News

Published: June 18, 2025, 4:01 p.m.
Endometrial Cancer Treatment Market Overview With Key USA Updates and Global Outlook - openPR.com

Endometrial Cancer Treatment Market Overview With Key USA Updates and Global Outlook openPR.com

Published: June 18, 2025, 7:49 a.m.
AstraZeneca’s ENHERTU Enters Pivotal Phase 3 Trial for Endometrial Cancer - MSN

AstraZeneca’s ENHERTU Enters Pivotal Phase 3 Trial for Endometrial Cancer MSN

Published: June 16, 2025, 11:46 a.m.
AstraZeneca’s ENHERTU Enters Pivotal Phase 3 Trial for Endometrial Cancer - Insider Monkey

AstraZeneca’s ENHERTU Enters Pivotal Phase 3 Trial for Endometrial Cancer Insider Monkey

Published: June 15, 2025, 9:42 a.m.
AstraZeneca’s ENHERTU Enters Pivotal Phase 3 Trial for Endometrial Cancer - Yahoo

AstraZeneca’s ENHERTU Enters Pivotal Phase 3 Trial for Endometrial Cancer Yahoo

Published: June 15, 2025, 9:39 a.m.
S2 Episode 6: Sequencing Antibody-Drug Conjugates in Endometrial Cancer - Medscape

S2 Episode 6: Sequencing Antibody-Drug Conjugates in Endometrial Cancer Medscape

Published: June 12, 2025, 1:50 p.m.
Daiichi announces first subject dosing in Enhertu trial for endometrial cancer - Yahoo

Daiichi announces first subject dosing in Enhertu trial for endometrial cancer Yahoo

Published: June 10, 2025, 9:47 a.m.
Daiichi announces first subject dosing in Enhertu trial for endometrial cancer - Clinical Trials Arena

Daiichi announces first subject dosing in Enhertu trial for endometrial cancer Clinical Trials Arena

Published: June 10, 2025, 9:06 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!